TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) just unveiled an update.
Aarti Drugs Limited has announced the publication of a newspaper article regarding the ‘Saksham Niveshak’ campaign, a 100-day initiative launched by the Investor Education and Protection Fund Authority. This campaign aims to enhance investor awareness and education, and its publication in prominent newspapers like Financial Express and Pratahkal underscores its importance. The initiative is expected to positively impact investor engagement and awareness, aligning with regulatory requirements and enhancing the company’s commitment to investor education.
More about Aarti Drugs Limited
Aarti Drugs Limited operates in the pharmaceutical industry, focusing on the production and distribution of active pharmaceutical ingredients (APIs), formulations, and specialty chemicals. The company is known for its extensive range of products catering to various therapeutic segments, and it plays a significant role in the global pharmaceutical supply chain.
Average Trading Volume: 32,648
Technical Sentiment Signal: Buy
Current Market Cap: 44.75B INR
Learn more about AARTIDRUGS stock on TipRanks’ Stock Analysis page.